Rapid Acceleration of Diagnostics (RADx®) Tech and ATP Programs
The RADx® Tech and ATP programs are supporting late-stage development of innovative point-of-care, home-based tests, and clinical laboratory tests.
Summary data on proposals submitted to the RADx® Tech and ATP Programs.
Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.
COVID-19 Research across NIBIB
NIBIB’s Dr. Kaitlyn Sadtler is a study lead and Principal Investigator working with NIH colleagues to test people who were infected with SARS-CoV-2 and developed antibodies but did not develop symptoms. Read about results from this study.
Learn how this collaborative network is using medical imaging and clinical data sciences to reveal unique features of COVID-19. Learn more about this resource.
View videos about RADx® Tech/ATP programs, interviews with the NIBIB Director and more.